Procalcitonin: inflammatory biomarker for assessing the severity of community-acquired pneumonia--a clinical observation in geriatric patients.

@article{Heppner2010ProcalcitoninIB,
  title={Procalcitonin: inflammatory biomarker for assessing the severity of community-acquired pneumonia--a clinical observation in geriatric patients.},
  author={Hans Juergen Heppner and Thomas Bertsch and Bettina Alber and Adelheid Sussanne Esslinger and Charalampos Dragonas and J{\"u}rgen M. Bauer and Cornel Christian Sieber},
  journal={Gerontology},
  year={2010},
  volume={56 4},
  pages={
          385-9
        }
}
Community-acquired pneumonia is a common disease of the elderly and involves a high mortality risk. Demographic developments are creating new challenges for acute medical treatment strategies in geriatric patients with their underlying multimorbidity. In addition to the diagnostic parameters recorded on hospital admission, such as white cell count and C-reactive protein, procalcitonin, more than the risk scores CRB- and CURB-65 evaluated to date, appears to be a promising parameter for… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 14 REFERENCES

Risikofaktoren für die community acquired pneumonia (Community Acquired Pneumonia) – Eine systematische Übersichtsarbeit

  • Y Kohlhammer, M Schwartz, H Raspe, T Schäfer
  • Dtsch Med Wochenzeitschr
  • 2005

Effect of procalcitoninguided treatment on antibiotic use and outcome in lower respiratory tract infections

  • M Christ-Crain
  • Lancet
  • 2004

Similar Papers

Loading similar papers…